Related Experiment Video
Updated: Jun 23, 2026

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
Published on: September 19, 2018
Quantifying cancer- and drug-induced changes in Shannon information capacity of RTK signaling
Paweł Nałęcz-Jawecki1, Lee Roth2, Frederic Grabowski1
1Institute of Fundamental Technological Research, Polish Academy of Sciences, Warsaw, Poland.
Abstract:
Signaling pathways transmit and process information, enabling cells to respond accurately to external cues. Disease states like cancer can corrupt signal transmission, though the magnitude to which they reduce information capacity has not been quantified. Here we apply pseudo-random pulsatile optogenetic stimulation, live-cell imaging, and information theory to compare the information capacity of receptor tyrosine kinase (RTK) signaling pathways in EML4-ALK-driven lung cancer cells (STE-1) and non-transformed lung epithelial cells (BEAS-2B). The information rate through the RTK/ERK pathway in STE-1 cells was below 0.5 bit/hour but increased to 3 bit/hour after oncogene inhibition. Information was transmitted by only 50-70% of cells, whose channel capacity (maximum information rate) was estimated through in silico protocol optimization. Although oncogene inhibition increased the capacity of the RTK/ERK pathway in STE-1 cells (6 bit/hour), capacity remained lower than in BEAS-2B (11 bit/hour). The capacity of the parallel RTK/calcineurin pathway in BEAS-2B exceeded 15 bit/hour. This study highlights information capacity as a sensitive metric for identifying disease-associated dysfunction and evaluating effects of targeted interventions.
Insights
Cancer disrupts cellular communication by reducing information capacity in signaling pathways. Inhibiting oncogenes improved information flow in lung cancer cells, but capacity remained lower than in healthy cells, revealing a new metric for disease assessment.
Area of Science:
- Cellular signaling and information theory
- Quantitative analysis of biological systems
Background:
- Cellular signaling pathways transmit external cues for accurate cell response.
- Cancer can impair signal transmission, but the impact on information capacity is unquantified.
Purpose of the Study:
- To quantify and compare information capacity in receptor tyrosine kinase (RTK) signaling pathways.
- To assess the impact of oncogene-driven cancer on cellular information processing.
- To evaluate the efficacy of targeted interventions using information capacity as a metric.
Main Methods:
- Utilized pseudo-random pulsatile optogenetic stimulation and live-cell imaging.
- Applied information theory to measure information rate and channel capacity.
- Employed in silico protocol optimization to estimate maximum information rates.
Main Results:
- RTK/ERK pathway information rate in lung cancer cells (STE-1) was low (<0.5 bit/hour), increasing to 3 bit/hour after oncogene inhibition.
- Information transmission occurred in only 50-70% of cancer cells.
- Oncogene inhibition increased STE-1 cell RTK/ERK pathway capacity to 6 bit/hour, still lower than in healthy BEAS-2B cells (11 bit/hour).
- The RTK/calcineurin pathway in BEAS-2B cells demonstrated a capacity exceeding 15 bit/hour.
Conclusions:
- Information capacity is a sensitive indicator of disease-associated signaling dysfunction.
- Targeted oncogene inhibition can partially restore signaling pathway capacity.
- This approach offers a novel method for evaluating therapeutic interventions in cancer.
Related Concept Videos
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Receptor Tyrosine Kinases
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

